Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...
X4 Summit 2026 is scheduled for March 17‑19, 2026, at the Seattle Convention Center. Qualtrics will host its flagship Experience Management conference in a city that reflects its market footprint and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results